Argo: a thawing in the resistance to a sale?
Recent developments including the temporary absence of CEO Kevin Rehnberg look to be a setback to the turnaround progress made by the Bermudian. Its repositioning as a US specialty insurer means it has a scarcity value that could be realised if its board and temporary management shift their stance
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below